Gentas has hired a number of world-renowned experts in large animal cloning, transgenic/targeting technology, animal models and new drug research and development to establish a scientific advisory committee. Committee experts are proficient in CRISPR/Cas9 gene editing technology and pig somatic cell nuclear transfer technology, as well as the application of large animals in new drug development and gene therapy. They have been the first to achieve breakthrough success in the world for many times, and have successfully established more than 50 kinds of genetically modified and genetically targeted cloned pigs with important value in the fields of biomedicine and agriculture. At the same time, forward and reverse genetics research is used to analyze the function of gene and signal transduction pathways in pigs, which provides an ideal large animal disease model for biomedical research, new drug development and clinical transformation of gene therapy. The attention of academic circles and large pharmaceutical companies also provides new strategies for the improvement of pig economic traits and the cultivation and improvement of strains. Many experts have successively won the Yangtze River Scholars Distinguished Professor, the National "Jieqing", the chief scientist of the "973" project, the national "Ten Thousand Talents Program" selected expert, the young and middle-aged scientific and technological innovation leader of the Ministry of Science and Technology, and the chief of the "Key R & D Project" of the Ministry of Science and Technology Scientist, The Chinese Academy of Sciences "Hundred Talents Program" introduces overseas outstanding talents and awards. The committee composed of scientific consultants at home and abroad provides strong strategic policies, strategies, science and technology and talent support for the company's development.
